Immunodiagnostics Market in China 2016-2020

中国の免疫診断市場:免疫診断試薬、免疫診断装置

◆タイトル:Immunodiagnostics Market in China 2016-2020
◆商品コード:IRTNTR7854
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年11月18日
◆ページ数:103
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、中国の免疫診断市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、中国の免疫診断市場規模及び予測、技術別分析、製品別分析、方式別分析、市場シェア、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

Covering: This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics.

Technavios market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period.

The rising prevalence of infectious and chronic diseases in this region is the primary growth driver for this market. In China, urbanization has led to an increase in the prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, and tuberculosis. This high prevalence of chronic diseases is envisaged to bolster the need for immunodiagnostic tests, which in turn would result in market growth during the forecast period.

The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.

The top vendors in the market are -
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthcare Diagnostics
- Beckman Coulter
- Sysmex Medical Electronics (Shangai)

Other prominent vendors in the market include AccuBio Tech,Alere,Becton Dickinson,Beijing Kewei Clinical Diagnostics Reagents, Beijing Leadman Biochemistry,Bio-RadBioscience Diagnostic Technology,Biosino Biotechnology & Science, DIAsource, DiaSys Diagnostic Systems, Fosun Pharma, Getein Biotechnology, Hitachi, Immunodiagnostic System Holdings, Luminex, NewScen Coast Bio-Pharmaceutical, Ortho Clinical Diagnostics, Shanghai Kehua Bio-engineering, Sichuan Maccura
Biotechnology, Tecan, and Thermofisher Scientific.

Technological segmentation of the immunodiagnostic market in China
- ELISA
- CLIA
- RIA
- FIA
- MIA
- LFIA

According to this global market research report, the chemiluminescence (CLIA) assay segment is anticipated to be the largest market segment during the forecast period. The ability of this assay to perform clinical applications at a rapid pace is a major factor that augments its adoption during the forecast period. Moreover, this assays ability to make sample detection sensitive and easy is envisaged to result in its profound market share of more than 66% by 2020.

Product-type segmentation and analysis of the immunodiagnostic market in China
- Reagent
- Instrument

Technavio market research analysts estimate the reagents segment to account for a market share of approximately 82% during the forecast period. The ability of reagents to diagnose minute quantities of biological agents like hormones, viruses, vitamins, or immunogenic substances in blood samples is anticipated to result in its high adoption during the predicted period.

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Healthcare system in China
Health insurance system in China
Regulatory landscape of China
Distribution network in China

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Market segmentation by product type
Immunodiagnostic reagents
Immunodiagnostic instruments
Immunodiagnostic reagents market in China
Immunodiagnostic instruments market in China

PART 08: Market segmentation by analyzer type

PART 09: Market segmentation by mode of operation

PART 10: Market segmentation by technology
CLIA market in China
ELISA market in China
FIA market in China
MIA market in China
LFIA market in China
RIA market in China

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape
Market share analysis
Analysis of tier 1 vendors

PART 17: Key vendor analysis
Abbott Diagnostics
Beckman Coulter Trading (China)
bioMrieux China
DiaSorin
Mindray
Roche Diagnostics
Siemens Healthcare Diagnostics (Shanghai)
Sysmex Medical Electronics (Shanghai)

PART 18: Appendix
List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Hospital distribution in China 2015
Exhibit 03: Hospital segmentation in China
Exhibit 04: Distribution of healthcare institutions in China
Exhibit 05: Health insurance system in China
Exhibit 06: Regulatory process for approval of medical devices in China
Exhibit 07: Distribution network in China 2013
Exhibit 08: Immunodiagnostics market in China
Exhibit 09: Immunodiagnostics market in China 2015-2020 ($ millions)
Exhibit 10: Five forces analysis
Exhibit 11: Immunodiagnostics market in China by product type
Exhibit 12: Segmentation of immunodiagnostics market in China by product type 2015
Exhibit 13: Segmentation of immunodiagnostics market in China by product type 2020
Exhibit 14: Immunodiagnostic reagents market in China market 2015-2020 ($ millions)
Exhibit 15: Immunodiagnostic instruments market in China 2015-2020 ($ millions)
Exhibit 16: Segmentation of immunodiagnostics market in China by analyzer type
Exhibit 17: Segmentation of immunodiagnostics market in China by analyzer type 2015
Exhibit 18: Segmentation by mode of operation
Exhibit 19: Segmentation of immunodiagnostics market in China by mode of operation 2015
Exhibit 20: Segmentation of the immunodiagnostics market in China by technology
Exhibit 21: Segmentation of immunodiagnostics market by technology 2015
Exhibit 22: Segmentation of immunodiagnostics market by technology 2020
Exhibit 23: CLIA market in China 2015-2020 ($ millions)
Exhibit 24: ELISA market in China 2015-2020 ($ millions)
Exhibit 25: FIA market in China 2015-2020 ($ millions)
Exhibit 26: MIA market in China 2015-2020 ($ millions)
Exhibit 27: LFIA market in China 2015-2020 ($ millions)
Exhibit 28: RIA market in China 2015-2020 ($ millions)
Exhibit 29: Segmentation of immunodiagnostics market in China by technology 2015-2020
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Competitive positioning of vendors
Exhibit 33: Abbott Diagnostics: Key takeaways
Exhibit 34: Beckman Coulter Diagnostics: Key takeaways
Exhibit 35: Roche Diagnostics: Key takeaways
Exhibit 36: Siemens Healthcare Diagnostics: Key takeaways
Exhibit 37: Abbott Diagnostics: Business segmentation
Exhibit 38: Beckman Coulter Trading (China): Business segmentation
Exhibit 39: bioMrieux China: Business segmentation
Exhibit 40: DiaSorin: Technology segmentation by revenue 2014
Exhibit 41: DiaSorin: Technology segmentation by revenue 2013 and 2014
Exhibit 42: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 43: Mindray: Business segmentation by revenue 2014
Exhibit 44: Mindray: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 45: Mindray: Geographical segmentation by revenue 2014
Exhibit 46: Mindray: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 47: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 48: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 49: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 50: Roche Diagnostics: Geographical segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 51: Roche Diagnostics: Sales in emerging markets
Exhibit 52: Siemens Healthcare Diagnostics (Shanghai): Business segmentation
Exhibit 53: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 (% share)
Exhibit 54: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 55: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2015
Exhibit 56: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2014 and 2015 ($ millions)



【掲載企業】

Abbott Diagnostics, Beckman Coulter Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, BioSino Bio-technology & Science, DiaSorin, Immunodiagnostic System Holdings (IDS), Mindray Medical International, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology


【資料のキーワード】

免疫診断試薬、免疫診断装置、免疫検査、中国

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[中国の免疫診断市場:免疫診断試薬、免疫診断装置] (Immunodiagnostics Market in China 2016-2020 / IRTNTR7854)販売に関する免責事項
[中国の免疫診断市場:免疫診断試薬、免疫診断装置] (Immunodiagnostics Market in China 2016-2020 / IRTNTR7854)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆